Accenture invests in Ocean Genomics
DUBLIN, IRELAND — Leading IT firm Accenture, which recently ranked Top 1 in the Time Doctor OA500, has invested in Ocean Genomics.
Terms of the investment were not disclosed.
The strategic investment aims to advance AI-driven drug discovery and develop personalized medicines.
Ocean Genomics, a Pennsylvania-based tech and AI company, develops software for biopharma firms that develop treatments based on a person’s biology.
Accenture is a global firm that provides a broad range of services across technology, consulting, and operations, among others. The company employs 738,000 people in over 120 countries.
Related news
- House of HR acquires German outsourcing firm · 1 Mar
- 761 call centers registered in Pakistan in 2022 · 1 Mar
- ibex named CX Outsourcing Leader · 28 Feb
Disclosure: Outsource Accelerator uses AI tools in the backend of its editorial workflow. Every article is reviewed and verified by a human editor before publication.
Stay ahead of the outsourcing industry. Join thousands of business leaders who rely on Outsource Accelerator for the news, trends, and expert insights that matter. Subscribe to our free newsletter and never miss an update.
